Fish oil medicine for heart plaque and recovery
Part of Heart & circulation clinical trials.
This study tests whether a prescription fish-oil medicine called icosapent ethyl can improve heart health by reducing plaques (fatty deposits) in the arteries, lowering inflammation, and helping the heart remodel (recover) after a heart event. It is designed for people with heart disease and high triglycerides.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with chronic coronary syndrome or acute coronary syndrome (types of heart disease).
- Your recent blood tests must show high triglycerides (a type of fat in the blood) of at least 1.7 mmol/L.
- You cannot be pregnant, planning pregnancy, or breastfeeding.
- You must not have a life-threatening illness that limits your life expectancy to less than 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a purified omega-3 fatty acid called icosapent ethyl can reduce inflammation and shrink high-risk plaques in your heart arteries. It uses a special PET/CT scan to see if the medicine helps stabilize these plaques over time.
This study tests whether a purified fish oil medicine called icosapent ethyl (IPE), taken along with your usual statin, can further lower the risk of heart attacks and strokes in people who already have heart or blood vessel disease. It aims to reduce the leftover risk even after standard cholesterol treatment.
This study tests whether a newer cholesterol-lowering injection, given early after a heart attack, helps keep the plaque in your arteries stable and reduces future risk. It compares the new medicine added to your usual statin treatment.
This trial tests if a medicine called icosapent ethyl can reduce inflammation in blood vessels for adults hospitalized with pneumonia. It aims to see if this treatment can help prevent complications.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.